Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Suzuki, Tatsuya ^a   Futami Suda, Shoko ^a   Igari, Yoshimasa ^a   Watanabe, Kentaro ^a   Ouchi, Motoshi ^a   Suzuki, Kazunari ^a   Sekimizu, Ken Ichi ^a   Kigawa, Yoshiaki ^b   Nakano, Hiroshi ^a   Oba, Kenzo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hanno Geriatric Hospital   (Japan)

Author keywords

Coronary heart disease; Lipoprotein (a) phenotype; Relative lymphocyte concentration

Indexed keywords

LIPOPROTEIN A; LOW MOLECULAR WEIGHT LIPOPROTEIN A; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LOW RELATIVE LYMPHOCYTE CONCENTRATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSPECTIVE STUDY; RISK FACTOR; WESTERN BLOTTING;

AGED; BIOLOGICAL MARKERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LIPOPROTEIN(A); LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEUTROPHILS; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

ANGINA;

EID: 84874605331     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-31     Document Type: Article

References (35)

1. Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. Rivera NV, BMC Med Genet 2013 23 14
2. Silent coronary artery disease in Japanese patients undergoing carotid artery stenting. Enomoto Y, J Stroke Cerebrovasc Dis 2013 pii: S1052-3057(12)00440-5. [Epub ahead of print] 10.1016/j.jstrokecerebrovasdis. 2012.12.013
3. White blood cell count and cardiovascular disease. Insights from the Framingham Study. Kannel WB, JAMA 1992 267 1253 1256 10.1001/jama.1992. 03480090101035 1538564
4. WBC count, atherosclerosis and coronary risk factors. Hasegawa T, J Atheroscler Thromb 2002 2 219 223
5. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Ommen SR, Am J Cardiol 1997 79 812 814 10.1016/S0002-9149(96)00878-8 9070569 (Pubitemid 27152347)
6. Incremental value of the differential and the rapid creatinine kinase-MB isoenzyme for the early diagnosis of MI. Thomson SP, Ann Intern Med 1995 122 335 341 7847644
7. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Zouridakis EG, Am J Cardiol 2000 86 449 451 10.1016/S0002-9149(00)00963-2 10946041 (Pubitemid 30628614)
8. Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Ozer N, Hear Vessel 2008 23 75 82 10.1007/s00380-007-1020-y (Pubitemid 351505880)
9. Seasonal variations in inflammatory responses to sepsis and stress in mice. Kiank C, Crit Care Med 2007 35 2352 2358 10.1097/01.CCM.0000282078.80187. 7F 17944025 (Pubitemid 47476234)
10. Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. Núñez J, Atherosclerosis 2009 206 251 257 10.1016/j.atherosclerosis.2009.01.029 19230894
11. Predictive value of the relative lymphocyte count in coronary heart disease. Bian C, Hear Vessel 2010 25 6 469 473 10.1007/s00380-010-0010-7
12. The mystery of lipoprotein (a). Utermann G, Science 1989 246 904 910 10.1126/science.2530631 2530631
13. Lp(a) lipoprotein as a risk factor for myocardial infarction. Rhoads GG, JAMA 1986 256 2540 2544 10.1001/jama.1986.03380180102027 2945939 (Pubitemid 17025291)
14. Four-year prospective study of the influence of elevated serum lipoprotein (a) concentration on ischemic heart disease and cerebral infarction in elderly patients with type-2 diabetes. Suzuki T, Geriatr Gerontol Int 2003 3 507 513
15. Genetics of plasma lipoprotein (a) concentrations. Boerwinkle E, Curr Op Lipid 1992 3 128 136 10.1097/00041433-199204000-00009
16. Revised equations for estimated GFR from serum creatinine in Japan. Matsuo S, Am J Kidney Dis 2009 53 982 992 10.1053/j.ajkd.2008.12.034 19339088
17. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Diabetol Int 2010 1 2 20 10.1007/s13340-010- 0006-7
18. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Fredewald WT, Clin Chem 1972 18 6 499 502 4337382
19. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. Utermann G, J Clin Invest 1987 80 458 465 10.1172/JCI113093 2956279
20. Lipoprotein (a): resurrected by genetics. Kronenberg F, J Intern Med 2012 273 6 30 22998429
21. Association of lipoprotein (a) levels and apolipoprotein (a) phenotypes with coronary heart disease in patients with essential hypertension. Gazzaruso C, J Hypertens 1997 15 227 235 10.1097/00004872-199715030-00003 9468449 (Pubitemid 27129111)
22. Relation of apolipoprotein (a) phenotypes to Diabetic retinopathy in elderly type 2 diabetes. Suzuki T, J Nippon Med Sch 2002 69 31 38 10.1272/jnms.69.31 11847507
23. Relationship of lipoprotein (a) and its phenotypes with albumin excretion rate in diabetic patients: A multivariate analysis. Hernandez C, Nephron 2000 85 27 33 10.1159/000045626 10773752 (Pubitemid 30242826)
24. T Research and Development Division, TOA medical Electronics Co. Ltd, Sysmex J 1993 16 174 191
25. Matsuno K, Standard Textbook of Laboratory Hematology: Chapter II. (The Japanese Society for Laboratory Hematology, 32-33) Tokyo: Ishiyaku Publishers 2003 In Japanese
26. Comparison of four leukocyte differential methods with the National Committee for Clinical Laboratory Standards (NCCLS) reference method. Pierre RV, Am J Clin Pathol 1987 87 201 209 3812351 (Pubitemid 17022459)
27. Apo(a) phenotyping and long-term prognosis for coronary artery disease. Baños-González MA, Clin Biochem 2010 43 640 644 10.1016/j.clinbiochem.2010.01.013 20153741
28. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. Bostom AG, The Framingham Heart Study. Circulation 1994 90 1688 1695 (Pubitemid 24320915)
29. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Paultre F, Arterioscler Thromb Vasc Biol 2000 20 2619 2624 10.1161/01.ATV.20.12.2619 11116062
30. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein (a). Ichinose A, Biochem Biophys Res Commun 1995 209 372 378 10.1006/bbrc.1995.1513 7726859
31. Atherosclerosis-an inflammatory disease. Ross R, N Engl J Med 1999 340 115 126 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
32. Chrousos GP, Mechanisms of physical and emotional stress. (Advances in Experimental Medicine and Biology, 245) New York: Plenum Press 1989
33. Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery. Naito Y, J Clin Endocrinol Metab 1991 73 111 117 10.1210/jcem-73-1-111 1646214 (Pubitemid 21901108)
34. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Hemingway H, Systematic review of prospective cohort studies 1999 318 1460 1467 (Pubitemid 29243707)
35. Stress, inflammation and cardiovascular disease. Black PH, J Psychosom Res 2002 52 1 23 10.1016/S0022-3999(01)00302-6 11801260 (Pubitemid 34130239)